Molecular mechanisms of apoptosis activation by heat shock in multidrug-resistant Chinese hamster cells

Radiation Research

Volumn 170, Issue 4, 2008, Pages 498-511

  Wrzal, Paulina K ^a   Bettaieb, Ahmed ^a   Averill Bates, Diana A ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 10; CASPASE 3; CASPASE 8; CYTOCHROME C; DEATH RECEPTOR; DOXORUBICIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; GLYCOPROTEIN P; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; MELPHALAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROCASPASE 9; PROTEIN BAX; PROTEIN BID; SURVIVIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HEAT SHOCK; HYPERTHERMIA; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE; CRICETINAE; CRICETULUS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HEAT-SHOCK RESPONSE; HYPERTHERMIA, INDUCED; MELPHALAN; MITOCHONDRIA; P-GLYCOPROTEIN; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION;

CRICETULUS GRISEUS;

EID: 55249098133     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1214.1     Document Type: Article

References (47)

1. V. Ling, Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol. 40 (Suppl.), S3-S8 (1997).
2. L. J. Dudley, Apoptosis in LR73 cells is inhibited by overexpression of the multidrug resistance (MDR) protein. J. Undergrad. Sci. 3, 8 (1998).
3. T. Fojo and S. Bates, Strategies for reversing drug resistance. Oncogene 22, 7512-7523 (2003).
4. K. S. Kim, Multifunctional role of Fas-associated death domain protein in apoptosis. J. Biochem. Mol. Biol. 35, 1-6 (2002).
5. G. S. Salvesen and V. M. Dixit, Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96, 10964-10967 (1999).
6. B. C. Barnhart, E. C. Alappat and M. E. Peter, The CD95 type I/type II model. Semin. Immunol. 15, 185-193 (2003).
7. S. Nagata, Apoptotic DNA fragmentation. Exp. Cell Res. 256, 12-18 (2000).
8. W. C. Earnshaw, L. M. Martins and S. H. Kaufmann, Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424 (1999).
9. J. D. Robertson, B. Zhivotovsky, V. Gogvadze and S. Orrenius, Outer mitochondrial membrane permeabilization: an open-and-shut case? Cell Death Differ. 10, 485-487 (2003).
10. A. Gross, BID as a double agent in cell life and death. Cell Cycle 5, 582-584 (2006).
11. J. van der Zee, Heating the patient: a promising approach? Ann. Oncol. 13, 1173-1184 (2002).
12. P. Wust, B. Hildebrandt, G. Sreenivasa, B. Rau, J. Gellermann, H. Riess, R. Felix and P. M. Schlag, Hyperthermia in combined treatment of cancer. Lancet Oncol. 3, 487-497 (2002).
13. D. L. Fraker, Management of in-transit melanoma of the extremity with isolated limb perfusion. Curr. Treat. Options Oncol. 5, 173-184 (2004).
14. B. Hildebrandt, J. Drager, T. Kerner, M. Deja, J. Loffel, C. Stroszczynski, O. Ahlers, R. Felix, H. Riess and P. Wust, Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I/II study. Int. J. Hyperthermia 20, 317-333 (2004).
15. E. L. Jones, J. R. Oleson, L. R. Prosnitz, T. V. Samulski, Z. Vujaskovic, D. Yu, L. L. Sanders and M. W. Dewhirst, Randomized trial of hyperthermia and radiation for superficial tumors. J. Clin. Oncol. 23, 3079-3085 (2005).
16. J. van der Zee and G. C. van Rhoon, Hyperthermia is effective in improving clinical radiotherapy results. Int. J. Radiat. Oncol. Biol. Phys. 66, 633-634 (2006).
17. C. Wendtner, S. Abdel-Rahman, J. Baumert, M. H. Falk, M. Krych, M. Santl, W. Hiddemann and R. D. Issels, Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur. J. Cancer 37, 1609-1616 (2001).
18. D. A. Bates and W. J. Mackillop, Hyperthermia, adriamycin transport, and cytotoxicity in drug-sensitive and -resistant Chinese hamster ovary cells. Cancer Res. 46, 5477-5481 (1986).
19. T. Souslova and D. A. Averill-Bates, Multidrug-resistant HeLa cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. Int. J. Radiat. Oncol. Biol. Phys. 60, 1538-1551 (2004).
20. D. A. Averill and C. Su, Sensitization to the cytotoxicity of adriamycin by verapamil and heat in multidrug-resistant Chinese hamster ovary cells. Radiat. Res. 151, 694-702 (1999).
21. C. Dumontet, F. Bodin and Y. Michal, Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance. Clin. Cancer Res. 4, 1563-1566 (1998).
22. B. Larrivee and D. A. Averill, Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia. Biochem. Pharmacol. 58, 291-302 (1999).
23. Y. Liu, K. Lillehei, W. N. Cobb, U. Christians and K. Y. Ng, Overcoming MDR by ultrasound-induced hyperthermia and P-glycoprotein modulation. Biochem. Biophys. Res. Commun. 289, 62-68 (2001).
24. G. Yokoyama, T. Fujii, E. Ogo, H. Yanaga, U. Toh, M. Yamaguchi, M. Mishima, S. Takamori, K. Shirouzu and H. Yamana, Advanced chemoresistant breast cancer responding to multidisciplinary treatment with hyperthermia, radiotherapy, and intraarterial infusion. Int. J. Clin. Oncol. 10, 139-143 (2005).
25. E. M. Elliott and V. Ling, Selection and characterization of Chinese hamster ovary cell mutants resistant to melphalan (l-phenylalanine mustard). Cancer Res. 41, 393-400 (1981).
26. S. Turcotte and D. A. Averill-Bates, Sensitization to the cytotoxicity of melphalan by ethacrynic acid and hyperthermia in drug-sensitive and multidrug-resistant Chinese hamster ovary cells. Radiat. Res. 156, 272-282 (2001).
27. A. Bettaieb and D. A. Averill-Bates, Thermotolerance induced at a mild temperature of 40°C protects cells against heat shock-induced apoptosis. J. Cell. Physiol. 205, 47-57 (2005).
28. H. R. Stennicke and G. S. Salvesen, Biochemical characteristics of caspases-3, -6, -7, and -8. J. Biol. Chem. 272, 25719-25723 (1997).
29. M. Jurkiewicz, D. A. Averill-Bates, M. Marion and F. Denizeau, Involvement of mitochondrial and death receptor pathways in tributyltin-induced apoptosis in rat hepatocytes. Biochim. Biophys. Acta 1693, 15-27 (2004).
30. Z. Darzynkiewicz, S. Bruno, G. Del Bino, W. Gorczyca, M. A. Hotz, P. Lassota and F. Traganos, Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808 (1992).
31. D. A. Averill-Bates, A. Cherif, E. Agostinelli, A. Tanel and G. Fortier, Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model. Biochem. Pharmacol. 69, 1693-1704 (2005).
32. A. A. Ruefli, K. M. Tainton, P. K. Darcy, M. J. Smyth and R. W. Johnstone, P-glycoprotein inhibits caspase 8 activation but not formation of the death inducing signal complex (disc) following Fas ligation. Cell Death Differ. 9, 1266-1272 (2002).
33. C. Friesen, I. Herr, P. H. Krammer and K. M. Debatin, Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2, 574-577 (1996).
34. K. M. Boatright, C. Deis, J. B. Denault, D. P. Sutherlin and G. S. Salvesen, Activation of caspases-8 and -10 by FLIP(L). Biochem. J. 382, 651-657 (2004).
35. O. Micheau, M. Thome, P. Schneider, N. Holler, J. Tschopp, D. W. Nicholson, C. Briand and M. G. Grutter, The long form of FLIP is an activator of caspase 8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277, 45162-45171 (2002).
36. C. Bonzon, L. Bouchier-Hayes, L. J. Pagliari, D. R. Green and D. D. Newmeyer, Caspase 2-induced apoptosis requires bid cleavage: a physiological role for bid in heat shock-induced death. Mol. Biol. Cell 17, 2150-2157 (2006).
37. U. Fischer, C. Stroh and K. Schulze-Osthoff, Unique and overlapping substrate specificities of caspase 8 and caspase 10. Oncogene 25, 152-159 (2006).
38. D. Milhas, O. Cuvillier, N. Therville, P. Clave, M. Thomsen, T. Levade, H. Benoist and B. Segui, Caspase 10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J. Biol. Chem. 280, 19836-19842 (2005).
39. B. Antonsson, S. Montessuit, B. Sanchez and J. C. Martinou, Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276, 11615-11623 (2001).
40. R. Eskes, S. Desagher, B. Antonsson and J. C. Martinou, Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20, 929-935 (2000).
41. T. Kuwana, M. R. Mackey, G. Perkins, M. H. Ellisman, M. Latterich, R. Schneiter, D. R. Green and D. D. Newmeyer, Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342 (2002).
42. S. Shimizu, M. Narita and Y. Tsujimoto, Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487 (1999).
43. I. Marzo, C. Brenner, N. Zamzami, J. M. Jurgensmeier, S. A. Susin, H. L. Vieira, M. C. Prevost, Z. Xie, S. Matsuyama and G. Kroemer, Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 281, 2027-2031 (1998).
44. A. Pohl, H. Lage, P. Muller, T. Pomorski and A. Herrmann, Transport of phosphatidylserine via MDR1 (multidrug resistance 1) P-glycoprotein in a human gastric carcinoma cell line. Biochem. J. 365, 259-268 (2002).
45. Y. Romsicki and F. J. Sharom, Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. Biochemistry 40, 6937-6947 (2001).
46. F. Luciani, A. Molinari, F. Lozupone, A. Calcabrini, L. Lugini, A. Stringaro, P. Puddu, G. Arancia, M. Cianfriglia and S. Fais, P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Blood 99, 641-648 (2002).
47. H. Grassme, A. Jekle, A. Riehle, H. Schwarz, J. Berger, K. Sandhoff, R. Kolesnick and E. Gulbins, CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276, 20589-20596 (2001).